Joe A. McCann, Chief Executive Officer at POINT Biopharma Global Inc. (PNT), bought 2,160 shares at $6.64 ($14K) on 2022-11-29, disclosed to the SEC on 2022-11-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.